J.W. Cole Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523K | Buy |
997
+34
| +4% | +$17.9K | 0.01% | 898 |
|
|
2025
Q1 | $611K | Buy |
963
+336
| +54% | +$213K | 0.02% | 707 |
|
|
2024
Q4 | $447K | Sell |
627
-175
| -22% | -$125K | 0.02% | 636 |
|
|
2024
Q3 | $843K | Buy |
802
+83
| +12% | +$87.3K | 0.04% | 436 |
|
|
2024
Q2 | $756K | Sell |
719
-36
| -5% | -$37.8K | 0.04% | 412 |
|
|
2024
Q1 | $727K | Sell |
755
-31
| -4% | -$29.9K | 0.04% | 420 |
|
|
2023
Q4 | $690K | Buy |
786
+6
| +0.8% | +$5.27K | 0.04% | 387 |
|
|
2023
Q3 | $642K | Sell |
780
-101
| -11% | -$83.1K | 0.05% | 352 |
|
|
2023
Q2 | $633K | Sell |
881
-62
| -7% | -$44.5K | 0.05% | 364 |
|
|
2023
Q1 | $775K | Buy |
943
+237
| +34% | +$195K | 0.06% | 341 |
|
|
2022
Q4 | $509K | Sell |
706
-13
| -2% | -$9.38K | 0.04% | 414 |
|
|
2022
Q3 | $495K | Sell |
719
-60
| -8% | -$41.3K | 0.04% | 401 |
|
|
2022
Q2 | $460K | Sell |
779
-63
| -7% | -$37.2K | 0.04% | 430 |
|
|
2022
Q1 | $588K | Sell |
842
-12
| -1% | -$8.38K | 0.04% | 409 |
|
|
2021
Q4 | $539K | Sell |
854
-39
| -4% | -$24.6K | 0.04% | 438 |
|
|
2021
Q3 | $540K | Sell |
893
-2
| -0.2% | -$1.21K | 0.04% | 244 |
|
|
2021
Q2 | $500K | Buy |
895
+457
| +104% | +$255K | 0.04% | 435 |
|
|
2021
Q1 | $207K | Sell |
438
-98
| -18% | -$46.3K | 0.02% | 619 |
|
|
2020
Q4 | $259K | Buy |
536
+46
| +9% | +$22.2K | 0.03% | 516 |
|
|
2020
Q3 | $274K | Buy |
+490
| New | +$274K | 0.02% | 574 |
|